PAUL STEVEN M purchased 85.7% of their position (35.71K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market purchase worth $974.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/22/2026ACC: 0001193125-26-429073
+35.71K
Net shares
Net buyer
$974.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
35.71K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+35.71K
Price / share
$27.28
Trade value
$974.28K
% of position
85.7%
10/22/2026
41.67K→77.38K
Total
Net shares
+35.71K
Net value
$974.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/22/2026 | P · Purchase | +35.71K | $27.28 | $974.28K | 85.7% | 41.67K | 77.38K |
| Total | +35.71K | $974.28K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned477.64K
Total
477.64K direct477.64K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 477.64K | Direct |
| Total | 477.64K | 477.64K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported